Navigational Bronchoscopy with Cryobiopsy for Diagnosis of ILD.


Journal

Case reports in pulmonology
ISSN: 2090-6846
Titre abrégé: Case Rep Pulmonol
Pays: United States
ID NLM: 101585355

Informations de publication

Date de publication:
2022
Historique:
received: 16 05 2022
accepted: 01 09 2022
entrez: 27 9 2022
pubmed: 28 9 2022
medline: 28 9 2022
Statut: epublish

Résumé

Interstitial lung diseases (ILDs) are a group of parenchymal pulmonary diseases in which pathologic diagnosis is essential. Although cryobiopsy has a high diagnostic yield, the complication rate remains high. LCB used with navigational guidance for the diagnosis of ILD provides may be a safe and effective procedure that provides high diagnostic yield. Limitations include cost, availability, and expertise. Larger trials are needed to confirm the additional benefit.

Sections du résumé

Background UNASSIGNED
Interstitial lung diseases (ILDs) are a group of parenchymal pulmonary diseases in which pathologic diagnosis is essential. Although cryobiopsy has a high diagnostic yield, the complication rate remains high.
Conclusion UNASSIGNED
LCB used with navigational guidance for the diagnosis of ILD provides may be a safe and effective procedure that provides high diagnostic yield. Limitations include cost, availability, and expertise. Larger trials are needed to confirm the additional benefit.

Identifiants

pubmed: 36164354
doi: 10.1155/2022/5128432
pmc: PMC9509241
doi:

Types de publication

Case Reports

Langues

eng

Pagination

5128432

Informations de copyright

Copyright © 2022 Fernando Figueroa Rodriguez et al.

Déclaration de conflit d'intérêts

The authors declare that they have no conflicts of interest.

Références

Med J Malaysia. 2019 Aug;74(4):349-351
pubmed: 31424050
Lung. 2021 Oct;199(5):485-492
pubmed: 34495390
J Thorac Dis. 2020 Apr;12(4):1595-1611
pubmed: 32395297
J Thorac Dis. 2019 Jan;11(1):329-334
pubmed: 30863611
Respiration. 2018;96(5):403-405
pubmed: 30300902
Lancet Respir Med. 2016 Jul;4(7):557-565
pubmed: 27180021
Am J Respir Crit Care Med. 2005 Aug 1;172(3):268-79
pubmed: 15879420
Respiration. 2016;91(3):215-27
pubmed: 26926876
BMC Pulm Med. 2019 Mar 1;19(1):56
pubmed: 30823915
BMJ Open Respir Res. 2021 Jan;8(1):
pubmed: 33441374

Auteurs

Fernando Figueroa Rodriguez (F)

Interventional Pulmonary Program, Section of Pulmonary, Critical Care and Sleep Medicine, The Oklahoma City VA Health Care System, USA.

Asfar Ghauri (A)

Interventional Pulmonary Program, Section of Pulmonary, Critical Care and Sleep Medicine, The Oklahoma City VA Health Care System, USA.

Tony Abdo (T)

Interventional Pulmonary Program, Section of Pulmonary, Critical Care and Sleep Medicine, The Oklahoma City VA Health Care System, USA.

Salim Daouk (S)

Interventional Pulmonary Program, Section of Pulmonary, Critical Care and Sleep Medicine, The Oklahoma City VA Health Care System, USA.

Shideler Barbara (S)

Interventional Pulmonary Program, Section of Pulmonary, Critical Care and Sleep Medicine, The Oklahoma City VA Health Care System, USA.

Houssein A Youness (HA)

Interventional Pulmonary Program, Section of Pulmonary, Critical Care and Sleep Medicine, The Oklahoma City VA Health Care System, USA.

Classifications MeSH